高于平均风险女性的乳腺癌筛查:ACR推荐
美国放射学会(ACR)发布推荐:平均风险女性从40岁起每年进行乳腺X线筛查;遗传相关高风险、终生风险≥20%或年轻时胸部/斗篷放疗者推荐补充对比增强乳腺MRI;有乳腺癌个人史且致密组织或50岁前诊断者也推荐MRI;有乳腺癌史或活检不典型增生者可考虑MRI监测;符合条件但不能行MRI者可考虑超声;所有女性尤其黑人女性和德系犹太人后裔应不晚于30岁评估风险。
要点
- 平均风险女性从40岁起每年乳腺X线筛查。
- 遗传相关高风险、终生风险≥20%或年轻胸部放疗者推荐补充对比增强乳腺MRI。
- 有乳腺癌个人史且致密组织或50岁前诊断者推荐MRI。
核心结论
- 早期发现降低乳腺癌死亡率;ACR推荐对高于平均风险女性进行风险分层并补充筛查,包括对比增强乳腺MRI和超声。
研究设计与样本
- 美国放射学会(ACR)发布的推荐(指南类),基于证据和专家共识形成。
诊断标准与关键数值
- 平均风险女性:从40岁起每年乳腺X线筛查。
- 遗传相关高风险(及未检测的一级亲属)、终生风险计算≥20%或年轻时胸部/斗篷放疗者:推荐补充对比增强乳腺MRI。
- 有乳腺癌个人史且致密组织或50岁前诊断者:推荐乳腺MRI。
- 有乳腺癌史或活检不典型增生者:可考虑MRI监测,尤其存在其他风险因素时。
- 符合条件但不能行MRI者:可考虑超声。
临床应用与阅片要点
- 对高于平均风险女性应早期启动乳腺X线筛查并评估补充MRI或超声的适应证,风险因素包括遗传、终生风险≥20%、年轻胸部放疗、乳腺癌个人史、致密组织和活检不典型增生;所有女性不晚于30岁进行风险评价。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Early detection decreases breast cancer mortality. The ACR recommends annual mammographic screening beginning at age 40 for women of average risk. Higher-risk women should start mammographic screening earlier and may benefit from supplemental screening modalities. For women with genetics-based increased risk (and their untested first-degree relatives), with a calculated lifetime risk of 20% or more or a history of chest or mantle radiation therapy at a young age, supplemental screening with contrast-enhanced breast MRI is recommended. Breast MRI is also recommended for women with personal histories of breast cancer and dense tissue, or those diagnosed by age 50. Others with histories of breast cancer and those with atypia at biopsy should consider additional surveillance with MRI, especially if other risk factors are present. Ultrasound can be considered for those who qualify for but cannot undergo MRI. All women, especially black women and those of Ashkenazi Jewish descent, should be evaluated for breast cancer risk no later than age 30, so that those at higher risk can be identified and can benefit from supplemental screening.
引用
- Monticciolo DL, Newell MS, Moy L, et al. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol. 2018. PMID: 29371086. doi:10.1016/j.jacr.2017.11.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。